Search

Displaying results 8801 - 8810 of 10000 in total
  1. Drug

    AG-24322

    go.drugbank.com/drugs/DB13035
    Investigational

    AG-024322 has been used in trials studying the treatment of Neoplasms and Lymphoma, Non-Hodgkin.

  2. Drug

    GDC-0349

    go.drugbank.com/drugs/DB13072
    Investigational

    GDC-0349 has been used in trials studying the treatment of Non-Hodgkin's Lymphoma, Solid Tumor.

  3. Drug

    Valnoctamide

    go.drugbank.com/drugs/DB13099
    Investigational

    Valnoctamide has been used in trials studying the treatment of Mania and Schizoaffective Disorder, Manic Type.

  4. Drug

    Artemisinin

    go.drugbank.com/drugs/DB13132
    Investigational

    Artemisinin has been used in trials studying the treatment of Schizophrenia, Malaria, Falciparum, and Plasmodium Falciparum.

  5. Drug

    Irosustat

    go.drugbank.com/drugs/DB02292
    Investigational

    Irosustat has been investigated for the treatment of Metastatic Breast Cancer and Locally Advanced Breast Cancer.

  6. Drug

    Neflamapimod

    go.drugbank.com/drugs/DB07138
    Investigational

    Neflamapimod has been used in trials studying the treatment of Alzheimer's Disease and Mild Cognitive Impairment.

  7. Drug

    Flutemetamol

    go.drugbank.com/drugs/DB15058
    Investigational

    Flutemetamol is under investigation in clinical trial NCT02353949 (Investigating the Clinical Consequences of Flutemetamol-PET-scanning).

  8. Drug

    MK-0482

    go.drugbank.com/drugs/DB17453
    Investigational

    MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT) 3.

  9. Drug

    rAAV9-rsATP7A

    go.drugbank.com/drugs/DB17664
    Experimental

    A recombinant adeno-associated viral vector gene therapy under investigation for the treatment of Menkes disease.

  10. Drug

    AMT-080

    go.drugbank.com/drugs/DB17846
    Experimental

    AMT-080 is an investigational gene therapy being investigated for the treatment of Duchenne muscular dystrophy.